Back to Journals » Therapeutics and Clinical Risk Management » Volume 1 » Issue 4

Changing personnel behavior to promote quality care practices in an intensive care unit

Authors Dominic Cooper, Keith Farmery, Martin Johnson, Christine Harper, Fiona L Clarke, et al

Published 15 December 2005 Volume 2005:1(4) Pages 321—332

Dominic Cooper1, Keith Farmery2, Martin Johnson3, Christine Harper3, Fiona L Clarke3, Phillip Holton4, Susan Wilson5, Paul Rayson6, Hugh Bence6

1Department of Applied Health Sciences, Indiana University, Bloomington, IN, USA; 2Consultant in Clinical Governance and Risk Management to Co Durham and Tees Valley Strategic Health Authority, Stockton on Tees, UK; 3James Cook University Hospital, Intensive Care Unit, Middlesbrough, UK; 4Co Durham and Tees Valley Strategic Health Authority, Stockton on Tees, UK; 5Primary Care Community Nursing, North Tees Primary Care Trust, Stockton on Tees, UK; 6Hunstman Petrochemicals (UK) Ltd, Redcar, Teesside, UK

Abstract: The delivery of safe high quality patient care is a major issue in clinical settings. However, the implementation of evidence-based practice and educational interventions are not always effective at improving performance. A staff-led behavioral management process was implemented in a large single-site acute (secondary and tertiary) hospital in the North of England for 26 weeks. A quasi-experimental, repeated-measures, within-groups design was used. Measurement focused on quality care behaviors (ie, documentation, charting, hand washing). The results demonstrate the efficacy of a staff-led behavioral management approach for improving quality-care practices. Significant behavioral change (F [6, 19] = 5.37, p < 0.01) was observed. Correspondingly, statistically significant (t-test [t] = 3.49, df = 25, p < 0.01) reductions in methicillin-resistant Staphylococcus aureus (MRSA) were obtained. Discussion focuses on implementation issues.

Keywords: behavioral management, hospital-acquired infection, goal-setting, feedback, employee involvement, methicillin-resistant Staphylococcus aureus (MRSA)

Download Article [PDF] 

Readers of this article also read:

The influence of dietary sodium content on the pharmacokinetics and pharmacodynamics of fimasartan

Gu N, Cho JY, Shin KH, Jang IJ, Rhee MY

Drug Design, Development and Therapy 2016, 10:1525-1531

Published Date: 19 April 2016

High glucose inhibits ClC-2 chloride channels and attenuates cell migration of rat keratinocytes

Pan F, Guo R, Cheng W, Chai L, Wang W, Cao C, Li S

Drug Design, Development and Therapy 2015, 9:4779-4791

Published Date: 28 August 2015

The association between the migration inhibitory factor -173G/C polymorphism and cancer risk: a meta-analysis

Zhang X, Weng WH, Xu W, Wang YL, Yu WJ, Tang X, Ma LF, Pan QH, Wang JY, Sun FY

OncoTargets and Therapy 2015, 8:601-613

Published Date: 10 March 2015


Marusza W, Mlynarczyk G, Olszanski R, Netsvyetayeva I, Obrowski M, Iannitti T, Palmieri B

International Journal of Nanomedicine 2012, 7:4119-4120

Published Date: 27 July 2012

Long-term treatment of osteoporosis: safety and efficacy appraisal of denosumab

Anastasilakis AD, Toulis KA, Polyzos SA, Anastasilakis CD, Makras P

Therapeutics and Clinical Risk Management 2012, 8:295-306

Published Date: 19 June 2012

Absorbable stent: focus on clinical applications and benefits

Gonzalo N, Macaya C

Vascular Health and Risk Management 2012, 8:125-132

Published Date: 29 February 2012

“One pill, once daily”: what clinicians need to know about Atripla™

Patrick G Clay, Tracey AH Taylor, Alan G Glaros, MaryPeace McRae, Charlott Williams, et al

Therapeutics and Clinical Risk Management 2008, 4:291-302

Published Date: 11 April 2008